Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hulisan
- Development stage
- Unknown
- Lead developer
- Xi'an Honghui Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Hulisan is a Traditional Chinese Medicine (TCM) herbal formulation primarily developed and utilized by Xi'an Honghui Hospital for the management of orthopedic pain and inflammation. It is designed to promote blood circulation, resolve blood stasis, and alleviate swelling and pain, making it a staple in orthopedic clinical practice in China. The drug is frequently employed as part of a multimodal analgesic strategy to manage postoperative pain in patients undergoing procedures such as total knee arthroplasty (TKA) and to treat chronic symptoms associated with knee osteoarthritis. Clinical research, including registered trials in the Chinese Clinical Trial Registry (ChiCTR), has evaluated its efficacy in reducing the consumption of systemic opioids and improving functional recovery outcomes in orthopedic patients.
- Brand names
- HuLisan
- Other names
- Huli San护力散
Beyond the preview
Go deeper on hulisan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hulisan.